Across TCGA pan-cancer cohorts, TRAJ4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TRAJ4’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where TRAJ4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRAJ4 is over-expressed in tumor.
KIRC and LUAD are the cancer types where TRAJ4 tumor–normal differential expression is most reproducible.